Latest News from: Roswell Park Comprehensive Cancer Center

Filters close
Newswise: Roswell Park Team Shows Dendritic-Cell Vaccines Can Be Paired With Standard Therapy for Breast Cancer
Released: 19-Jul-2021 5:05 PM EDT
Roswell Park Team Shows Dendritic-Cell Vaccines Can Be Paired With Standard Therapy for Breast Cancer
Roswell Park Comprehensive Cancer Center

A Roswell Park Comprehensive Cancer Center team reports new data on the promise of combining standard treatment for breast cancer with a particular form of cancer immunotherapy — dendritic-cell (DC) treatment vaccines.

Newswise: Roswell Park Experts Highlight Opportunities to Improve Outcomes for People with Gastroesophageal Cancer
Released: 2-Jul-2021 2:00 PM EDT
Roswell Park Experts Highlight Opportunities to Improve Outcomes for People with Gastroesophageal Cancer
Roswell Park Comprehensive Cancer Center

Two Roswell Park Comprehensive Cancer Center experts were invited to present new insights on treatment of gastroesophageal cancers during the European Society for Medical Oncology (ESMO) World Congress on Gastrointestinal Cancer 2021. In their talks, both presented July 1, the Roswell Park physician-researchers highlighted easily adoptable methods that may help other clinicians to provide care supporting improved patient outcomes.

Newswise: Roswell Park Teams Draw More Than $34 Million in Grants Supporting New Research
Released: 30-Jun-2021 2:50 PM EDT
Roswell Park Teams Draw More Than $34 Million in Grants Supporting New Research
Roswell Park Comprehensive Cancer Center

Even as the COVID-19 pandemic took hold, Roswell Park Comprehensive Cancer Center scientists continued to draw support for their innovative research proposals, garnering more than $34 million in competitive grants from government agencies and private funders. These recent grants fund efforts to improve outcomes for patients with some of the most challenging cancer types — including triple-negative breast cancer, pancreatic cancer and head and neck cancers — and to advance what we know about the impact of COVID-19 in cancer patients.

Released: 9-Jun-2021 3:05 PM EDT
New Insights on Sarcomatoid Kidney Cancer: Roswell Park Reports Clear Benefit from Checkpoint Inhibitors
Roswell Park Comprehensive Cancer Center

New collaborative research shows that treatment with immune checkpoint inhibitors (ICIs) has led to a significant improvement in survival and response rates among patients with a particularly aggressive type of kidney cancer: advanced sarcomatoid renal cell carcinoma. The study, which was led by a team from Roswell Park Comprehensive Cancer Center and involved contributors from six centers, is detailed in a presentation at the American Society of Clinical Oncology 2021 virtual annual meeting (abstract 4568).

Released: 9-Jun-2021 1:05 PM EDT
Breast Cancer Study: African Americans Not Experiencing Complete Response to Extent Other Groups Are
Roswell Park Comprehensive Cancer Center

Researchers at Roswell Park Comprehensive Cancer Center led the largest study to date to suggest an improving trend in pathologic complete response rates over time for U.S. cancer patients of various races. The team's findings, documented in a poster presentation at the 2021 American Society of Clinical Oncology virtual annual meeting (abstract 575), show that African Americans are more likely than patients from any other group to have remaining disease following breast cancer treatment.

Released: 9-Jun-2021 12:10 PM EDT
Biomarker Uncovered by Roswell Park Team Identifies NET Patients Likely to Have Blood Side Effects from PRRT
Roswell Park Comprehensive Cancer Center

New work from a team at Roswell Park Comprehensive Cancer Center will help guide the care of patients with neuroendocrine tumors, or NETs. In a poster presentation at the American Society of Clinical Oncology (ASCO) virtual Annual Meeting 2021, Abhay Singh, MD, MPH, and colleagues outline their discovery of a potential biomarker to predict which patients are likely to experience blood toxicity side effects from a new targeted radiation treatment, peptide receptor radionuclide therapy (PRRT).

Newswise: 20201117_zsiros-055.jpg
4-Jun-2021 9:00 PM EDT
Roswell Park Team Demonstrates Safe Approach for Dramatically Reducing Use of Opioids Following Surgery
Roswell Park Comprehensive Cancer Center

A pain-management protocol designed by Emese Zsiros, MD, PhD, FACOG, to be reported at the American Society of Clinical Oncology 2021 annual meeting, resulted in a 45% decrease in opioids prescribed to patients undergoing surgery, without significant effect on recovery or satisfaction.

Newswise: Research From Roswell Park and Kaiser Permanente Supports Vitamin D Supplementation for Breast Cancer Patients
Released: 4-Jun-2021 5:10 PM EDT
Research From Roswell Park and Kaiser Permanente Supports Vitamin D Supplementation for Breast Cancer Patients
Roswell Park Comprehensive Cancer Center

The Roswell Park Comprehensive Cancer Center/Kaiser Permanente Northern California team behind a new study to be highlighted at the ASCO 2021 virtual annual meeting has found that sufficient vitamin D levels at the time of diagnosis are associated with improved outcomes among people with breast cancer.

Released: 3-Jun-2021 5:10 PM EDT
Roswell Park Researchers Gear Up for ASCO 2021 Annual Meeting
Roswell Park Comprehensive Cancer Center

At the American Society of Clinical Oncology 2021 virtual Annual Meeting, Roswell Park teams will share data and insights on topics ranging from reducing use of opioids to an analysis of trends in response to cancer treatment among patients of different races.

Newswise: Top Cancer Centers Call for Urgent Action to Get Cancer-Preventing HPV Vaccination Back on Track
Released: 20-May-2021 2:05 PM EDT
Top Cancer Centers Call for Urgent Action to Get Cancer-Preventing HPV Vaccination Back on Track
Roswell Park Comprehensive Cancer Center

As part of a unanimous effort on the part of the nation’s 71 National Cancer Institute (NCI)-designated cancer centers, Roswell Park Comprehensive Cancer Center is urging the nation’s physicians, parents and young adults to get cancer-preventing human papillomavirus (HPV) vaccination back on track.

Newswise: Dr. Elisa Rodriguez Named Roswell Park’s First-Ever Chief Diversity and Equity Officer for Faculty
Released: 14-May-2021 5:20 PM EDT
Dr. Elisa Rodriguez Named Roswell Park’s First-Ever Chief Diversity and Equity Officer for Faculty
Roswell Park Comprehensive Cancer Center

A new role as Chief Diversity and Equity Officer for Faculty will give Roswell Park Comprehensive Cancer Center's Elisa M. Rodriguez, PhD, MS, expanded opportunity to apply her deep-rooted commitment to improving the lives of people from underserved communities.

Newswise: Renowned Roswell Park Immunologist Promoted to Endowed Chair Role
Released: 12-May-2021 10:05 AM EDT
Renowned Roswell Park Immunologist Promoted to Endowed Chair Role
Roswell Park Comprehensive Cancer Center

Following a national search, Roswell Park Comprehensive Cancer Center has promoted Pawel Kalinski, MD, PhD, to Jacobs Family Endowed Chair of Immunology, Chief of the Division of Translational Immuno-Oncology and Senior Vice President for Team Science.

Newswise: Roswell Park, Wilmot Cancer Institute Collaborate on First Large Study of Immunotherapy in Black Cancer Patients
Released: 20-Apr-2021 3:45 PM EDT
Roswell Park, Wilmot Cancer Institute Collaborate on First Large Study of Immunotherapy in Black Cancer Patients
Roswell Park Comprehensive Cancer Center

A new collaboration between two Western New York cancer research leaders will help oncologists learn whether Black and white cancer patients respond differently to a game-changing immunotherapy treatment, and seeks to improve the safety and effectiveness of these newer drugs in diverse populations.

Newswise:Video Embedded cancer-patients-who-are-most-worried-about-finances-shown-to-have-worse-outcomes
VIDEO
Released: 9-Mar-2021 10:45 AM EST
Cancer Patients Who Are Most Worried About Finances Shown to Have Worse Outcomes
Roswell Park Comprehensive Cancer Center

Cancer treatment is likely to affect every aspect of a patient’s life — their activities, relationships, eating habits, mental health, physical health and comfort, financial wellbeing. And when financial concerns weigh heavily on an individual who is in treatment for cancer, they can affect the outcome of that treatment. New research from Roswell Park Comprehensive Cancer Center provides the first evidence that a cancer patient’s level of financial worry as they begin treatment predicts how likely it is that their treatment will be successful.

Newswise: Roswell Park Researchers Identify New Biomarker of Response to Checkpoint Inhibitors
Released: 3-Mar-2021 12:00 PM EST
Roswell Park Researchers Identify New Biomarker of Response to Checkpoint Inhibitors
Roswell Park Comprehensive Cancer Center

A team of Roswell Park Comprehensive Cancer Center researchers has identified a new biomarker that could predict response to immune checkpoint inhibitors (ICI) shortly after patients with non-small cell lung cancer (NSCLC) initiate therapy. This discovery, published today in the journal Nature Communications, is not only an important step forward in lung cancer treatment, but also has implications for other malignancies, according to lead author Fumito Ito, MD, PhD, FACS.

Newswise: Roswell Park Awarded Nearly $2 Million to Study Cause of Racial Disparities in Breast Cancer
Released: 16-Feb-2021 5:05 PM EST
Roswell Park Awarded Nearly $2 Million to Study Cause of Racial Disparities in Breast Cancer
Roswell Park Comprehensive Cancer Center

A research team headed by Roswell Park Comprehensive Cancer Center epidemiologist Zhihong Gong, PhD, has been awarded a five-year, $1.9 million grant from the National Cancer Institute for an investigation into the role that certain genetic molecules play in breast cancer disparities.

Newswise: Aggressive Breast Cancers in Black Patients Related to Immune Factors, Roswell Park Team Reveals
Released: 5-Jan-2021 11:45 AM EST
Aggressive Breast Cancers in Black Patients Related to Immune Factors, Roswell Park Team Reveals
Roswell Park Comprehensive Cancer Center

A Roswell Park Comprehensive Cancer Center team led by Christine Ambrosone, PhD, and Song Yao, PhD, has revealed a distinct molecular signature in the tumor tissues of Black patients with breast cancer. The new work, published today in JNCI, the Journal of the National Cancer Institute, reports that an elevated number of “exhausted,” nonfunctional T cells appears to be driving tumors in patients of African descent to be more aggressive and hard-to-treat — a finding that also opens the door to treatment interventions that could help to eliminate the striking disparities in survival between Black and white patients with breast cancer.

Newswise: huss-wei-foster-paragh-color_dec2020-1.jpg
Released: 4-Jan-2021 8:10 AM EST
Roswell Park Experts Use Gene Sequencing to Quantify Risk of Skin Cancer Long Before Damage is Visible
Roswell Park Comprehensive Cancer Center

In a study published today in the journal Science Advances, a team from Roswell Park details a method to measure the abundance of cancer-related early changes to skin tissue long before the damage becomes visible to the eye.

Newswise: merz-maximilian-md-landscape.jpg
Released: 7-Dec-2020 5:05 PM EST
Sequencing Study from Roswell Park Highlights Previously Unknown Myeloma Resistance Mechanisms
Roswell Park Comprehensive Cancer Center

— A group of researchers led by Maximillian Merz, MD, Assistant Professor of Oncology with the Myeloma team at Roswell Park Comprehensive Cancer Center, conducted the first prospective clinical trial investigating spatial heterogeneity in patients with either relapsed/refractory or newly diagnosed multiple myeloma. Findings from the study will be presented today at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, which is being held virtually.

Newswise: Hernandez-Ilizaliturri_Francisco.jpg
Released: 7-Dec-2020 4:50 PM EST
Novel Therapy is Safe for Non-Hodgkin Lymphoma Patients, Roswell Park-Led Study Finds
Roswell Park Comprehensive Cancer Center

Roswell Park Comprehensive Cancer Center’s Francisco J. Hernandez-Ilizaliturri, MD, along with a team of researchers from other institutions, has been investigating a novel therapy for patients with relapsed or refractory B-cell non-Hodgkin lymphoma. Dr. Hernandez-Ilizaliturri will present the team’s findings today at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, which is being held virtually.

Newswise: crop20200723_dr.wanglab-070-x3.jpg
Released: 7-Dec-2020 8:20 AM EST
Roswell Park Leukemia Chief Shares Promising Findings on New Treatment Options at ASH 2020
Roswell Park Comprehensive Cancer Center

Today, during the ASH Annual Meeting and Exposition, Eunice Wang, MD, Chief of Leukemia and Director of Infusion Services at Roswell Park Comprehensive Cancer Center, is presenting data on two ongoing studies incorporating new treatment options for AML.

Newswise: #MaskUp to Drive COVID-19 Numbers Back Down, Nation’s Healthcare Leaders Urge
Released: 19-Nov-2020 1:30 PM EST
#MaskUp to Drive COVID-19 Numbers Back Down, Nation’s Healthcare Leaders Urge
Roswell Park Comprehensive Cancer Center

Roswell Park Comprehensive Cancer Center is among 100 of the nation’s top health care systems, representing thousands of hospitals in communities across the U.S., that have come together with an urgent plea for all Americans: mask up, because wearing a face mask is our best chance at slowing the surging COVID-19 pandemic now.

Newswise: Roswell Park Reports Positive Outcomes from New Combination Treatment for Ovarian Cancer
Released: 19-Nov-2020 1:30 PM EST
Roswell Park Reports Positive Outcomes from New Combination Treatment for Ovarian Cancer
Roswell Park Comprehensive Cancer Center

A team from Roswell Park Comprehensive Cancer Center has detailed striking findings on the effectiveness of a previously untried combination of old and new drugs as treatment for recurrent ovarian cancer.

Newswise: What Drives Painful Bone Metastasis in Prostate Cancer, and Can it Be Prevented?
Released: 18-Nov-2020 12:05 PM EST
What Drives Painful Bone Metastasis in Prostate Cancer, and Can it Be Prevented?
Roswell Park Comprehensive Cancer Center

While prostate cancer originates within the prostate, metastasis, or the spread of a tumor from the site of origin to other organs, remains a leading cause of death among people with the disease. Prostate tumors can metastasize to a number of different organs, including the liver, lymph nodes and bone.

Newswise: shipra-gandhi-landscape.jpg
Released: 30-Oct-2020 2:05 PM EDT
Roswell Park Sees Suggestion of Benefit in First Clinical Trial to Combine Beta-Blocker and Checkpoint Inhibitor
Roswell Park Comprehensive Cancer Center

The same biochemical triggers that spur a “fight or flight” response when we encounter threats may help tumor cells to thrive. A team of researchers from Roswell Park Comprehensive Cancer Center is looking at ways to disrupt that dynamic so that cancer treatments can be more effective. Their latest work, published today in Clinical Cancer Research, a journal of the American Association for Cancer Research, suggests that a drug widely prescribed to control blood pressure may improve patients’ response to cancer immunotherapy.

Newswise: fumito-ito-porthole.jpg
Released: 27-Oct-2020 2:30 PM EDT
New Roswell Park Strategy for Overcoming Resistance to Immunotherapy Unleashes Power of Dendritic Cells
Roswell Park Comprehensive Cancer Center

Research led by a team from Roswell Park Comprehensive Cancer Center details a promising new strategy for overcoming resistance to immunotherapy by zeroing in on dendritic cells and enhancing their function as “accessory cells” supporting other immune cells.

Newswise:Video Embedded niagara-falls-miracle-baby-beats-aggressive-leukemia-after-successful-car-t-cancer-immunotherapy-in-buffalo
VIDEO
Released: 1-Oct-2020 9:30 AM EDT
Niagara Falls ‘Miracle’ Baby Beats Aggressive Leukemia After Successful CAR-T Cancer Immunotherapy in Buffalo
Roswell Park Comprehensive Cancer Center

“She’s a bundle of joy, she’s a blessing. She’s just life.” That’s what Cariorl Mayfield of Niagara Falls, NY, says about his young daughter, Chasity, a year after she went through a complex series of therapies at the Roswell Park Oishei Children’s Cancer and Blood Disorders Program to treat the leukemia she was diagnosed with at only 5 weeks old.

Newswise: Deep Look at Immune Cells in Patients’ Tumors Reveals Insights on Timing for Treatment Combinations
Released: 8-Sep-2020 2:00 PM EDT
Deep Look at Immune Cells in Patients’ Tumors Reveals Insights on Timing for Treatment Combinations
Roswell Park Comprehensive Cancer Center

It’s clear that radiation therapy, or radiotherapy, an approach used to treat cancer since the early 20th century, can be an effective companion to newer, immune-stimulating approaches known as immunotherapy. Research from a team from Roswell Park Comprehensive Cancer Center explains how radiation helps boost the immune system’s ability to fight cancer in combination with immune checkpoint inhibitors — and provides new evidence that the timing of these therapies can make a big difference in how effectively they work together.

Newswise: chen-george-porthole.jpg
Released: 25-Aug-2020 12:50 PM EDT
Roswell Park Study: Delaying Antiviral Treatment May Boost Immunity in Stem Cell Transplant Recipients
Roswell Park Comprehensive Cancer Center

Patients who develop cytomegalovirus infections after allogeneic stem cell transplantation may be able to develop an immunity against the virus, strengthen their immune system and reduce reliance on strong antiviral medications, a team from Roswell Park reports in the journal Biology of Blood and Marrow Transplantation.

Newswise: 20200813_dr.-singh-032-1.jpg
Released: 24-Aug-2020 5:05 PM EDT
New Study Suggests Role for Hormone Therapy to Treat Even Small, T1a Breast Cancers
Roswell Park Comprehensive Cancer Center

Many people diagnosed with breast cancers that are small but invasive could benefit from hormone treatment, a new study led by physicians at Roswell Park Comprehensive Cancer Center confirms. Their findings were published today in the journal JAMA Network Open.

Newswise: Use of Pembrolizumab Provided Long-Term Benefits in Patients With Metastatic Melanoma, 10-Year Look Shows
Released: 16-Jul-2020 4:05 PM EDT
Use of Pembrolizumab Provided Long-Term Benefits in Patients With Metastatic Melanoma, 10-Year Look Shows
Roswell Park Comprehensive Cancer Center

A new 10-year analysis led by Igor Puzanov, MD, MSci, FACP, Director of Early Phase Clinical Trials and Chief of Melanoma at Roswell Park Comprehensive Cancer Center and published today in the journal JAMA Oncology provides new insights into an important question: whether BRAF V600E/K mutation status or previous BRAF inhibitor (BRAFi) therapy with or without a MEK inhibitor (MEKi) affects response to pembrolizumab (brand name Keytruda) in patients with advanced melanoma.

Newswise: iyer-renuka-landscape.jpg
Released: 14-Jul-2020 11:00 AM EDT
Roswell Park Studies Highlight Emerging Treatment Options for Neuroendocrine Tumors
Roswell Park Comprehensive Cancer Center

Two new studies led by Renuka Iyer, MD, Section Chief for Gastrointestinal Oncology at Roswell Park Comprehensive Cancer Center, highlight possible new treatment options for patients with neuroendocrine tumors (NETs) — a rare and hard-to-treat cancer.

Newswise: Number of Hospitalizations Can Be Important Clinical Indicator for Head, Neck Cancer Patients
Released: 30-Jun-2020 4:00 PM EDT
Number of Hospitalizations Can Be Important Clinical Indicator for Head, Neck Cancer Patients
Roswell Park Comprehensive Cancer Center

Patients who were unexpectedly hospitalized for dehydration, fever or other ailments while undergoing radiation treatment for head and neck cancers were at a higher risk for less favorable outcomes, a new study from Roswell Park Comprehensive Cancer Center reports.

Newswise: gvhd-small-intestine-cells_hmohammadpourjpg.jpg
Released: 12-Jun-2020 12:30 PM EDT
Roswell Park Suggests New Strategy for Controlling Graft vs. Host Disease in Blood/Marrow Transplant Recipients
Roswell Park Comprehensive Cancer Center

New preclinical work by a team of researchers from Roswell Park Comprehensive Cancer Center’s Transplant and Cellular Therapy Program suggests that the risk of developing acute graft vs. host disease (GVHD) during allogeneic blood/marrow transplant (BMT) — a potentially curative treatment for selected patients with hematologic disorders — can be decreased using an existing class of drugs called beta adrenergic agonists.

Newswise: adobestock_331558247.jpg
Released: 9-Jun-2020 5:30 PM EDT
Cancer Researchers Have a Head Start in Fight Against COVID-19
Roswell Park Comprehensive Cancer Center

Researchers at Roswell Park Comprehensive Cancer Center have been actively engaged in the effort to develop treatments or other control strategies that can help communities worldwide to address the impacts of the COVID-19 pandemic.

Newswise: Decisions to Stray From Clinical Oncology Pathways Are Often Justified, Roswell Park Analysis Shows
Released: 29-May-2020 1:25 PM EDT
Decisions to Stray From Clinical Oncology Pathways Are Often Justified, Roswell Park Analysis Shows
Roswell Park Comprehensive Cancer Center

Clinical oncology pathways are an important tool, helping cancer care providers and their patients to zero in on the most appropriate care plan. But a treating professional’s decision to depart from the recommendations of these decision-support resources may be well-founded and in the patient’s best interests, a new Roswell Park study shows.

Newswise: thota_swapna.jpg
Released: 29-May-2020 11:05 AM EDT
Targeted Drugs and Immunotherapies May Lower Risk of Therapy-Related Hematologic Cancers
Roswell Park Comprehensive Cancer Center

While breakthrough treatments have emerged for several cancers over the last two decades, driving striking improvements in survival and other clinical outcomes, too little is known about the risk of therapy-related hematologic cancers following targeted and immunotherapeutic approaches. In a study to be presented at the American Society of Clinical Oncology (ASCO) 2020 virtual meeting, a Roswell Park Comprehensive Cancer Center team reports that in many cases, these newer treatment approaches may reduce the risk of therapy-related myelodysplastic syndrome or acute myeloid leukemia (tMDS/AML) compared to chemotherapy-based treatment strategies.

Newswise: Roswell Park Team Proposes Strategy for Making Pancreatic Tumors Respond to Checkpoint Inhibition
Released: 18-May-2020 10:15 AM EDT
Roswell Park Team Proposes Strategy for Making Pancreatic Tumors Respond to Checkpoint Inhibition
Roswell Park Comprehensive Cancer Center

A possible new strategy for treating pancreatic cancer highlights the promise of collaboration between experts in both precision medicine and immunology. The findings from a team led by Agnieszka Witkiewicz, MD, and Erik Knudsen, PhD, at Roswell Park Comprehensive Cancer Center and published today in the journal Gut suggest a combination treatment approach that can make some breakthrough immunotherapy drugs effective for more patients with pancreatic cancer.

Newswise: Roswell Park to Assess Investigational Immunotherapy Combination in Cancer Patients With COVID-19
Released: 12-May-2020 11:35 AM EDT
Roswell Park to Assess Investigational Immunotherapy Combination in Cancer Patients With COVID-19
Roswell Park Comprehensive Cancer Center

A two-drug immunotherapy combination first proposed by a Roswell Park team as an approach for treating cancer will soon be available to cancer patients with COVID-19 through a clinical trial at the Buffalo, N.Y., cancer center.

Newswise: kelly_kara_porthole.jpg
Released: 1-May-2020 2:40 PM EDT
Diet Rich in Antioxidants Can Reduce Risk of Infection in Pediatric Leukemia Patients
Roswell Park Comprehensive Cancer Center

New research led by a pediatric oncology expert from Roswell Park Comprehensive Cancer Center underscores that diets high in antioxidant-rich foods can have particular benefits for young cancer patients.

Newswise: Aggressive Prostate Cancer Marked by Abnormal RNA Splicing, Roswell Park Team Reveals
Released: 29-Apr-2020 1:35 PM EDT
Aggressive Prostate Cancer Marked by Abnormal RNA Splicing, Roswell Park Team Reveals
Roswell Park Comprehensive Cancer Center

Aggressive forms of prostate cancer don’t act the way they should, hanging on to genetic materials called introns that should be thrown away, researchers from Roswell Park reported today in Nature Communications.

Newswise: Chronic Stress Can Impact Response to Radiation Therapy for Cancer, Roswell Park Study Suggests
Released: 14-Apr-2020 6:50 PM EDT
Chronic Stress Can Impact Response to Radiation Therapy for Cancer, Roswell Park Study Suggests
Roswell Park Comprehensive Cancer Center

Radiation is one of the oldest and most common therapies for cancer, and typically is delivered locally, or to specific targeted sites in the body. While it has long been thought that locally-delivered radiation therapy typically does not help to shrink tumors outside the field of irradiation, new preclinical research from a team at Roswell Park Comprehensive Cancer Center suggests a strategy for significantly increasing both the local and distant, or “abscopal,” effects of radiation. Results of the study, which was led by Elizabeth Repasky, PhD, have been newly published in Nature Communications.

Newswise: Roswell Park to Offer Convalescent Plasma to Patients with Severe COVID-19
Released: 14-Apr-2020 6:05 AM EDT
Roswell Park to Offer Convalescent Plasma to Patients with Severe COVID-19
Roswell Park Comprehensive Cancer Center

Roswell Park will offer plasma from the donated blood of healthy individuals who have had COVID-19 but have now fully recovered to patients with severe or life-threatening COVID-19 through an expanded access program authorized by the U.S. FDA.

Released: 3-Apr-2020 4:05 PM EDT
Roswell Park Reports Extended Survival Among Breast Cancer Survivors Who Exercise Regularly
Roswell Park Comprehensive Cancer Center

New research from Roswell Park Comprehensive Cancer Center, published in the Journal of the National Cancer Institute, shows that following those guidelines can improve clinical outcomes for patients with high-risk breast cancer, or breast cancer that is likely to recur or spread.

Newswise: Roswell Park’s Dr. Pawel Kalinski to Lead $14.5M NCI-Funded Immunotherapy Effort
Released: 31-Mar-2020 2:30 PM EDT
Roswell Park’s Dr. Pawel Kalinski to Lead $14.5M NCI-Funded Immunotherapy Effort
Roswell Park Comprehensive Cancer Center

A team led by Pawel Kalinski, MD, PhD, of Roswell Park Comprehensive Cancer Center has earned a five-year, $14.54 million award from the National Cancer Institute (NCI) to expand a promising immunotherapy platform. Funded through the NCI’s Program Project Grant program, this prestigious five-year grant will fund five clinical trials, all focused on a strategy for making some of the most common immunotherapies work for more cancer patients.

Newswise: Metabolic Pathway Can Be Effectively Targeted to Treat Prostate Cancer, Roswell Park Team Shows
Released: 27-Feb-2020 5:50 PM EST
Metabolic Pathway Can Be Effectively Targeted to Treat Prostate Cancer, Roswell Park Team Shows
Roswell Park Comprehensive Cancer Center

A Roswell Park team has identified a new strategy for treating prostate cancer — the first to target metabolic processes uniquely important to prostate cancer.

Newswise:Video Embedded roswell-park-finds-new-evidence-that-inhaled-vitamin-e-acetate-caused-evali-in-vapers
VIDEO
Released: 27-Feb-2020 5:40 PM EST
Roswell Park Finds New Evidence That Inhaled Vitamin E Acetate Caused EVALI in Vapers
Roswell Park Comprehensive Cancer Center

A team of researchers from Roswell Park Comprehensive Cancer Center and the CDC report new evidence that inhalation of vitamin E acetate is strongly linked to e-cigarette, or vaping, product use-associated lung injury (EVALI).

Newswise: Roswell Park Team Identifies New Tumor Suppressor Protein in Prostate Cancer
Released: 3-Dec-2019 11:10 AM EST
Roswell Park Team Identifies New Tumor Suppressor Protein in Prostate Cancer
Roswell Park Comprehensive Cancer Center

A research team led by Dr. Dean Tang at Roswell Park Comprehensive Cancer Center has identified the molecule LRIG1 as an important endogenous tumor suppressor in prostate cancer.

Newswise: Roswell Park Spinoff Company Advances Toward New Clinical Trial for Brain Cancer Immunotherapy SurVaxM
Released: 20-Nov-2019 10:15 AM EST
Roswell Park Spinoff Company Advances Toward New Clinical Trial for Brain Cancer Immunotherapy SurVaxM
Roswell Park Comprehensive Cancer Center

The inventors of a cancer immunotherapy developed at Roswell Park Comprehensive Cancer Center have announced a major step forward with that therapy, SurVaxM — a multimillion-dollar licensing deal that will help enable large, randomized clinical trials in both the U.S. and China.

Newswise: Algorithm Reduces Need for Therapy in Children With Intermediate-Risk Neuroblastoma
Released: 2-Oct-2019 9:50 AM EDT
Algorithm Reduces Need for Therapy in Children With Intermediate-Risk Neuroblastoma
Roswell Park Comprehensive Cancer Center

Roswell Park's Dr. Clare Twist led an effort to develop and validate a new treatment algorithm for infants and children with neuroblastoma. In a new study in the Journal of Clinical Oncology, the team reports that many patients can safely receive less extensive therapy.


Showing results

150 of 375

close
0.3444